F13A1 and Alzheimer disease: Consistently, LC–MS/MS coupled with PiB‐PET imaging revealed that three of the candidates were altered significantly in AD brain tissues, which suggests that pro‐protein convertase PCSK9, F13A1, and DCD could be potential candidate biomarkers for early diagnosis of AD.